John Lewis
7Patents
1h-index
14Co-inventors
44Inventor score
Filing activity: Sep 29, 2011 → Dec 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10227386B2 | Recombinant polypeptides for membrane fusion and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11459362B2 | Recombinant polypepties for membrane fusion and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9846167B2 | Method for detecting and monitoring bone loss | Physics | 0 | Active |
| US11603543B2 | Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein | Chemistry; Metallurgy | 0 | Active |
| US12421514B2 | Methods for diagnosing and treating metastatic cancer | Physics | 0 | Active |
| US11236331B2 | Methods for diagnosing and treating metastatic cancer | Physics | 0 | Active |
| US9789213B2 | EGFL7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.